$0.02
0.00% day before yesterday
Nasdaq, Aug 18, 03:30 pm CET

Codex DNA Inc Stock price

$0.02
-0.00 9.47% 1M
-0.35 94.13% 6M
-0.38 94.50% YTD
-3.54 99.38% 1Y
-36.88 99.94% 3Y
-332.98 99.99% 5Y
-332.98 99.99% 10Y
-332.98 99.99% 20Y
Nasdaq, Closing price Tue, Aug 19 2025
+0.00 0.00%

Key metrics

Basic
Market capitalization
$1.7m
Enterprise Value
$3.6m
Net debt
$1.9m
Cash
$4.5m
Shares outstanding
1.8m
Valuation (TTM | estimate)
P/E
negative | 0.0
P/S
0.1 | 0.2
EV/Sales
0.3 | 0.4
EV/FCF
negative
P/B
0.5
Financial Health
Equity Ratio
42.0%
Return on Equity
-166.0%
ROCE
-166.9%
ROIC
-170.5%
Debt/Equity
1.7
Financials (TTM | estimate)
Revenue
$13.5m | $9.4m
EBITDA
$-28.1m | $-18.6m
EBIT
$-30.2m | $-26.2m
Net Income
$-47.9m | $-45.0m
Free Cash Flow
$-23.7m
Growth (TTM | estimate)
Revenue
-54.9% | -65.9%
EBITDA
19.3% | 43.5%
EBIT
18.2% | 25.4%
Net Income
-23.2% | 8.1%
Free Cash Flow
33.1%
Margin (TTM | estimate)
Gross
47.3%
EBITDA
-207.3% | -197.8%
EBIT
-223.4%
Net
-354.1% | -480.0%
Free Cash Flow
-175.5%
More
EPS
$-27.0
FCF per Share
$-13.4
Short interest
7.3%
Employees
39
Rev per Employee
$710.0k
Show more

Is Codex DNA Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Codex DNA Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Codex DNA Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Codex DNA Inc forecast:

Buy
86%
Hold
14%

Financial data from Codex DNA Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
14 14
55% 55%
100%
- Direct Costs 7.13 7.13
37% 37%
53%
6.41 6.41
66% 66%
47%
- Selling and Administrative Expenses 25 25
32% 32%
188%
- Research and Development Expense 11 11
37% 37%
83%
-28 -28
19% 19%
-207%
- Depreciation and Amortization 2.18 2.18
0% 0%
16%
EBIT (Operating Income) EBIT -30 -30
18% 18%
-223%
Net Profit -48 -48
23% 23%
-354%

In millions USD.

Don't miss a Thing! We will send you all news about Codex DNA Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Codex DNA, Inc. engages in research and development of genomic tools for biomedical and industrial applications. It offers BioXp 3200 system and Gibson assembly reagents. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.

Head office United States
CEO Eric Esser
Employees 39
Founded 2011
Website telesisbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today